pharmaphorum | News & views on pharma and biotech’s evolving …
pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
Novartis raises mid-term sales outlook on pipeline promise
2 days ago — Novartis said this morning that its pipeline includes more than 30 high-value projects that allow it to achieve sales growth of 6% or more between out to 2029, a point higher than its …
About pharmaphorum
Nov 15, 2024 — pharmaphorum.com is a leading online destination for healthcare and pharmaceutical industry news, insight, and debate – as is its associated digital magazine Deep …
pharmaphorum - The Deep Dive Digital Magazine has fresh …
Feb 28, 2024 — Digital Health 2023. 29-11-2023 Deep Dive – Digital Health 2023 features interviews, analysis, and commentary from pharmaphorum, Lumanity, AXON, Viseven, …
Deep Dive: Patients & Partnerships 2024 | pharmaphorum
Nov 8, 2024 — Delve into the critical issues surrounding patients, partnerships, and the US election in 2024. Explore the impact on drug development, pricing, and patient access in this in-depth …
Pharma in the age of acceleration - pharmaphorum
That’s not to say that they have to rigidly adhere to the way pharma works, but there’s certainly a need for a highly collaborative approach and the generation of data that people will believe, …
News | Timely industry updates for pharma and biotech leaders
pharmaphorum’s news coverage updates daily with the latest pharma and biotech stories, from funding and M&A to regulatory approvals and policy shifts.
Patients want to be heard. Is pharma listening? - pharmaphorum
For example, the term patient-centricity has been a buzzword that many patient advocacy groups say is just a label. “In a survey we conducted of 22 advocacy groups regarding the term …
Pills and polls: What the 2024 election means for pharma
Nov 14, 2024 — President Biden’s passage of the Inflation Reduction Act, which, among many other provisions, allowed Medicare to negotiate drug prices for the first time and set a $35-per …
Building a strong pharma brand - pharmaphorum
This is when companies need to capture and listen to real-time feedback and this needs to go beyond simple sales numbers. To really understand how the product is being received, ‘softer’ …